ALDX
Price
$5.17
Change
-$0.27 (-4.96%)
Updated
Jul 25 closing price
Capitalization
309.66M
13 days until earnings call
CANF
Price
$0.98
Change
-$0.03 (-2.97%)
Updated
Jul 25 closing price
Capitalization
13.94M
Interact to see
Advertisement

ALDX vs CANF

Header iconALDX vs CANF Comparison
Open Charts ALDX vs CANFBanner chart's image
Aldeyra Therapeutics
Price$5.17
Change-$0.27 (-4.96%)
Volume$1.76M
Capitalization309.66M
Can-Fite BioPharma
Price$0.98
Change-$0.03 (-2.97%)
Volume$234.84K
Capitalization13.94M
ALDX vs CANF Comparison Chart in %
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. CANF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and CANF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ALDX: $5.17 vs. CANF: $0.98)
Brand notoriety: ALDX and CANF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 163% vs. CANF: 209%
Market capitalization -- ALDX: $309.66M vs. CANF: $13.94M
ALDX [@Biotechnology] is valued at $309.66M. CANF’s [@Biotechnology] market capitalization is $13.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileCANF’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • CANF’s FA Score: 1 green, 4 red.
According to our system of comparison, ALDX is a better buy in the long-term than CANF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 2 TA indicator(s) are bullish while CANF’s TA Score has 5 bullish TA indicator(s).

  • ALDX’s TA Score: 2 bullish, 4 bearish.
  • CANF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CANF is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -4.08% price change this week, while CANF (@Biotechnology) price change was -5.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ALDX is expected to report earnings on Nov 13, 2025.

CANF is expected to report earnings on Apr 14, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($310M) has a higher market cap than CANF($13.9M). ALDX YTD gains are higher at: 3.607 vs. CANF (-39.692). CANF has higher annual earnings (EBITDA): -7.79M vs. ALDX (-55.54M). ALDX has more cash in the bank: 90.1M vs. CANF (4.73M). CANF has less debt than ALDX: CANF (57K) vs ALDX (15.6M). CANF has higher revenues than ALDX: CANF (667K) vs ALDX (0).
ALDXCANFALDX / CANF
Capitalization310M13.9M2,230%
EBITDA-55.54M-7.79M713%
Gain YTD3.607-39.692-9%
P/E RatioN/AN/A-
Revenue0667K-
Total Cash90.1M4.73M1,906%
Total Debt15.6M57K27,368%
FUNDAMENTALS RATINGS
ALDX vs CANF: Fundamental Ratings
ALDX
CANF
OUTLOOK RATING
1..100
827
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
3689
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CANF's Valuation (33) in the Biotechnology industry is in the same range as ALDX (47). This means that CANF’s stock grew similarly to ALDX’s over the last 12 months.

ALDX's Profit vs Risk Rating (91) in the Biotechnology industry is in the same range as CANF (100). This means that ALDX’s stock grew similarly to CANF’s over the last 12 months.

ALDX's SMR Rating (97) in the Biotechnology industry is in the same range as CANF (99). This means that ALDX’s stock grew similarly to CANF’s over the last 12 months.

ALDX's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for CANF (89). This means that ALDX’s stock grew somewhat faster than CANF’s over the last 12 months.

ALDX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CANF (100). This means that ALDX’s stock grew similarly to CANF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXCANF
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 26 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSSI28.952.00
+7.42%
TSS.Inc
NCL0.19N/A
+2.06%
Northann Corp
BAX29.220.45
+1.56%
Baxter International
AUB33.08-0.01
-0.03%
Atlantic Union Bankshares Corp
SHIP7.14-0.17
-2.33%
Seanergy Maritime Holdings Corp

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-4.96%
CANF - ALDX
46%
Loosely correlated
-2.97%
CMVLF - ALDX
39%
Loosely correlated
N/A
CLLS - ALDX
39%
Loosely correlated
+26.00%
CGON - ALDX
39%
Loosely correlated
-0.15%
PLRX - ALDX
38%
Loosely correlated
-1.26%
More